ACTG Publications

TitleAuthorsDateJournalIssueVolume
Antiretroviral therapies in women after single-dose nevirapine exposure.Lockman, Shahin ; Hughes, Michael D ; McIntyre, James ; Zheng, Yu ; Chipato, Tsungai ; Conradie, Francesca ; Sawe, Fred ; Asmelash, Aida ; Hosseinipour, Mina C ; Mohapi, Lerato ; Stringer, Elizabeth ; Mngqibisa, Rosie ; Siika, Abraham ; Atwine, Diana ; Hakim, James ; Shaffer, Douglas ; Kanyama, Cecilia ; Wools-Kaloustian, Kara ; Salata, Ro2010 Oct 14N Engl J Med16363
Cardiovascular disease risk factors in HIV-infected women after initiation of lopinavir/ritonavir- and nevirapine-based antiretroviral therapy in Sub-Saharan Africa: A5208 (OCTANE).Shaffer, Douglas ; Hughes, Michael D ; Sawe, Fredrick ; Bao, Yajing ; Moses, Agnes ; Hogg, Evelyn ; Lockman, Shahin ; Currier, Judith2014 Jun 1J Acquir Immune Defic Syndr266
Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial.Lockman, Shahin ; Hughes, Michael ; Sawe, Fred ; Zheng, Yu ; McIntyre, James ; Chipato, Tsungai ; Asmelash, Aida ; Rassool, Mohammed ; Kimaiyo, Sylvester ; Shaffer, Douglas ; Hosseinipour, Mina ; Mohapi, Lerato ; Ssali, Francis ; Chibowa, Margret ; Amod, Farida ; Halvas, Elias ; Hogg, Evelyn ; Alston-Smith, Beverly ; Smith, Laura ; Schoole2012PLoS Med69
Predictors of suboptimal CD4 response among women achieving virologic suppression in a randomized antiretroviral treatment trial, Africa.Asmelash, Aida ; Zheng, Yu ; Kaloustian, Kara Wools ; Shaffer, Douglas ; Sawe, Fred ; Ogwu, Anthony ; Salata, Robert ; Currier, Judith ; Hughes, Michael D ; Lockman, Shahin2014BMC Infect Dis14